[1] Zhou Li, Yu Bin, Gao Mengqiu, Chen Rui, Li Zhiyu, Gu Yueqing*, Bian Jinlei*, Ma Yi*. DNA framework-engineered chimeras platform enables selectively targeted protein degradation[J]. Nature Communications, 2023, 14(1): 4510.
[2] Li Changsheng, Lin Qiao, Hu Fangrong, Bao Ruichu, Cai Huiming, Gu Yueqing*. Based on lapatinib innovative near-infrared fluorescent probes targeting HER1/HER2 for in vivo tumors imaging[J]. Biosensors and Bioelectronics, 2022, 214: 114503.
[3] Zhai Yuewen, He Xiaorong, Li Ying, Han Ran, Ma Yuying, Gao Peng, Qian Zhiyu, Gu Yueqing*, Li Siwen*. A splenic-targeted versatile antigen courier: iPSC wrapped in coalescent erythrocyte-liposome as tumor nanovaccine[J]. Science Advances, 2021, 7(35): eabi6326.
[4] Ma Yi, Ma Yuxuan, Gao Mengqiu, Han Zhihao, Jiang Wen, Gu Yueqing*, Liu Yi*. Platelet‐Mimicking Therapeutic System for Noninvasive Mitigation of the Progression of Atherosclerotic Plaques[J]. Advanced Science, 2021, 8(8): 2004128.
[5] Zhaohui Wang, Yi Ma, Xiyuan Yu, Qi Niu, Zhihao Han, Han Wang, Tingting Li, Dingping Fu, Samuel Achilefu, Zhiyu Qian, Yueqing Gu*. Targeting CXCR4–CXCL12 axis for visualizing, predicting, and inhibiting breast cancer metastasis with theranostic AMD3100–Ag2S quantum dot probe[J]. Advanced Functional Materials, 2018, 28(23): 1800732.